Maven Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,890
| Closed | -$979K | – | 242 |
|
|
2019
Q3 | $979K | Buy |
+10,890
| New | +$979K | 0.31% | 57 |
|
|
2018
Q4 | – | Sell |
-6,672
| Closed | -$822K | – | 145 |
|
|
2018
Q3 | $822K | Buy |
+6,672
| New | +$822K | 0.3% | 78 |
|
|
2017
Q1 | – | Sell |
-567
| Closed | -$21K | – | 59 |
|
|
2016
Q4 | $21K | Buy |
+567
| New | +$21K | 0.02% | 42 |
|